Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025 In post hoc analysis of the pivotal RESILIENT study, TONMYA produced rapid pain relief as early as Day 2 ...

RAP-219's lead program demonstrated robust and consistent activity in patients with focal onset seizures (FOS) in Phase 2a trial; initiation of Phase 3 program expected in the second quarter of 2026RA ...

Partnership leverages Tenacia’s expertise in central nervous system (CNS) drug development and commercialization to accelerate U.S. and global development of RAP-219 Tenacia obtains exclusive rights ...

Lundbeck seems to have brought its migraine prevention drug bocunebart back on track, after dropping development of one formulation of the anti-PACAP antibody last year. Results from the phase 2b ...

Globally, alcohol is losing ground , an estimated $830 billion has been wiped off the sector’s market value in just four ...

VOLTAS, a medical device development manufacturing company, opens its new facility built to support medical device ...

As AI Enters Its Accountability Era, Million Dollar AI Prompts Positions Structure as the Defining Advantage NEW YORK, ...

Plans to License or Monetize our Migraine and Inhalation Assets Continue FRAMINGHAM, Mass., Feb. 26, 2026 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") ...

Share price of NTPC hit a new 52-week high at ₹388.50, gaining 2 per cent on the BSE in Wednesday’s intra-day trade on healthy business outlook. In the past one month, the stock price of the ...

The NSE Nifty IT index has tumbled 21 per cent so far in the month of February, and now quotes at its lowest level (30,053) since August 2023 amid the AI-triggered sell-off. India is seen as a reverse ...

ET Online An engaging panel discussion explored how Vadodara’s MSMEs can build on their manufacturing capabilities to emerge as leaders in the next phase of industrial expansion. The ET Make in India ...

New Delhi-based corporate car rental service provider WTicab plans to strengthen its position in the overseas market after establishing a strong foothold in India. The company, which clocked ₹523 ...